세계의 마이크로 플루이딕스 시장 2024-2030 : 용도별 (의료/헬스 케어, 비의료), 재료별 (실리콘, 유리), 기술별, 지역별

■ 영문 제목 : Microfluidics Market Size, Share & Trends Analysis Report By Application (Medical/Healthcare, Non-Medical), By Material (Silicon, Glass), By Technology, By Region, And Segment Forecasts, 2024 - 2030

Grand View Research가 발행한 조사보고서이며, 코드는 GRV24JAN047 입니다.■ 상품코드 : GRV24JAN047
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 11월
■ 페이지수 : 200
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기 : 3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 바이오
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD5,950 ⇒환산₩8,032,500견적의뢰/주문/질문
Multi User (5인 열람용)USD6,950 ⇒환산₩9,382,500견적의뢰/주문/질문
Global/corporate License (기업 열람용)USD8,950 ⇒환산₩12,082,500견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 마이크로 플루이딕스 시장의 성장과 동향
Grand View Research, Inc.사의 최신 보고서에 따르면,세계의 마이크로 플루이딕스 시장 규모는 2024년부터 2030년까지 12.22%의 CAGR을 기록하며 2030년에는 719억 달러에 이를 것으로 예상됩니다. 온칩 생화학 분석을 가능하게 하는 디지털 마이크로플루이딕스와 같은 개선된 기술의 도입으로 마이크로플루이딕스 기반 기기에 대한 수요가 증가할 것으로 예상됩니다. 분석 및 임상 연구자들의 연구 활동 증가도 미세유체 장치의 수요를 증가시키는 요인으로 작용하고 있습니다. 예를 들어, 2022년 5월 미네소타 대학교 연구팀은 최소한의 부품만 사용하고 스마트폰으로 무선으로 조작할 수 있는 혁신적인 질병 진단용 미세유체 칩을 개발했습니다.

소형 마이크로 플루이딕스 기반 도구는 소비자들 사이에서 큰 인기를 얻고 있으며, 이는 기업의 개발 투자를 촉진하고 있습니다. 마이크로유체공학은 랩온어칩 디바이스의 기본 원리로, 최소 샘플량, 최소 시약 사용, 폐기물 감소, 빠른 처리 등 다양한 이점이 있습니다. 향상된 기능의 전자동 마이크로유체학 및 강력한 모듈성은 이 시장에서 사업을 운영하는 제조업체에게 성장 기회를 제공하고 있습니다. 이는 모듈형 칩이 여러 장비와 인터페이스할 수 있기 때문입니다. 또한, 신약 개발 분야의 기업들은 특허가 만료되는 약품이 많기 때문에 예상되는 수익 감소를 상쇄하기 위해 제반 비용과 타임라인을 최소화하기 위해 노력하고 있습니다.

진단 분야, 특히 POC 진단 분야에서 미세유체공학의 도입이 확대되고 있습니다. 이는 POC 진단을 강화할 것으로 기대되는 미세유체 일체형 바이오 센서 기술에 의해 보완되고 있습니다. 미세유체 부품과 POC 장치의 조합은 민감도, 안정성, 정확성, 경제성을 달성하고 저침습적 POC 기술을 얻는 데 초점을 맞추고 있습니다. 미세 유체 POC 기술은 개인화, 질병 조기 발견 및 쉬운 모니터링을 보장하여 환자 치료를 강화할 것으로 예상됩니다.

또한, 코로나19는 미세유체공학의 활용을 더욱 확대했습니다. 현장 진료 검사는 소형 장비를 사용하여 프로세스를 제어하고 검사 주기를 제한합니다. 이를 통해 단일 또는 여러 실험실 서비스가 생물학적 샘플을 평가하고 유해한 질병을 동시에 진단 할 수 있습니다. 일반적으로 바이러스 전염병의 단계적 평가와 신속한 탐지는 전염병 상황을 극복하고 신속하게 진단하는 데 필수적입니다. 따라서 미세 유체 장치와 현장 검사를 결합하여 검출 효율을 높일 수 있습니다. 동시에 미세 유체 칩을 이용한 현장 검사는 사용자의 편의성을 높이고 감도와 정확도를 향상시키며 감지 시간을 단축할 수 있습니다.

2021년 6월, 다나하(Danaher Corporation)는 캐나다에 본사를 둔 솔루션 제공 업체인 Precision Nano Systems(PNI)를 생명과학 사업부가 인수했다고 발표했습니다. PNI는 마이크로 플루이딕스 기반 플랫폼을 통한 LNP 전달 및 나노 입자 제조를 포함한 독자적인 유전자 툴킷 플랫폼을 제공하여 회사의 생명과학 제품 포트폴리오를 더욱 보완하는 데 도움이 될 것으로 기대했습니다.

한편, 높은 운영 비용은 마이크로 플루이딕스 시장의 성장을 어느 정도 저해하고 있습니다. 마이크로 플루이딕스 칩 제조에는 최종 밀폐 구조를 형성하기 위해 기계 부품을 접착해야 하는 개방형 채널 구조와 같은 문제가 있습니다. 개방형 채널은 유리나 실리콘을 에칭하여 형성됩니다. 이 단계는 시간이 오래 걸리고 비용이 많이 들며 공격적인 화학 물질을 사용해야 합니다. 또한, 대부분의 마이크로 플루이딕스 프로토타이핑 방법은 배치 프로세스를 지원하지 않으며, 복잡하고 비용이 많이 듭니다.

마이크로 플루이딕스 시장 보고서 하이라이트

- 용도별로는 의료 분야가 2023년 시장에서 가장 높은 매출 점유율을 차지할 것으로 예상되며, 2024-2030년 CAGR은 12.56%로 예측됩니다.

- 재료별로는 폴리디메틸실록산(PDMS) 분야가 2023년 가장 높은 시장 점유율을 차지하고 2024-2030년 CAGR은 13.59%로 예측됩니다.

- 기술별로는 랩온칩 부문이 2023년 시장을 지배할 것으로 예상되며, 예측 기간 동안 11.06%의 CAGR을 기록할 것으로 예상됩니다.

- 북미는 2023년 42.69%의 매출 점유율로 시장을 지배하고 예측 기간 동안 10.57%의 CAGR을 기록할 것으로 예상되고 있습니다.
■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 시장 변수/동향/범위
4. 세계의 마이크로 플루이딕스 시장 규모 : 용도별 비즈니스 분석
5. 세계의 마이크로 플루이딕스 시장 규모 : 재료별 비즈니스 분석
6. 세계의 마이크로 플루이딕스 시장 규모 : 기술별 비즈니스 분석
7. 세계의 마이크로 플루이딕스 시장 규모 : 지역별 비즈니스 분석
8. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Application & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Application & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for low-volume sample analysis
3.2.1.2. Growing penetration of microfluidics in diagnostics market
3.2.1.3. Introduction of advanced technologies
3.2.2. Market Restraint Analysis
3.2.2.1. High operational cost
3.2.2.2. Interfacing and integration
3.2.2.3. Complex fabrication process
3.2.3. Market Opportunity Analysis
3.2.3.1. Investments by companies in technological advancements
3.2.3.2. Growing adoption of point-of-care (POC) tests
3.2.3.3. Expansion of application scope for microfluidics technology
3.3. Industry Analysis Tools
3.3.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.3.2. Porter’s Five Forces Analysis
3.4. COVID-19 Impact Analysis
Chapter 4. Microfluidics Market: Application Business Analysis
4.1. Microfluidics Market: Application Movement Analysis
4.2. Medical
4.2.1. PCR & RT-PCR
4.2.1.1. Global PCR & RT-PCR Market, 2018 – 2030 (USD Million)
4.2.2. Gel electrophoresis
4.2.2.1. Global Gel electrophoresis Market, 2018 – 2030 (USD Million)
4.2.3. Microarrays
4.2.3.1. Global Microarrays Market, 2018 – 2030 (USD Million)
4.2.4. ELISA
4.2.4.1. Global ELISA Market, 2018 – 2030 (USD Million)
4.2.5. Others
4.2.5.1. Global Others Market, 2018 – 2030 (USD Million)
4.3. Non-Medical
4.3.1. Global Non-Medical Market, 2018 – 2030 (USD Million)
Chapter 5. Microfluidics Market: Material Business Analysis
5.1. Microfluidics Market: Material Movement Analysis
5.2. Silicon
5.2.1. Global Silicon Market, 2018 – 2030 (USD Million)
5.3. Glass
5.3.1. Global Glass Market, 2018 – 2030 (USD Million)
5.4. Polymer
5.4.1. Global Polymer Market, 2018 – 2030 (USD Million)
5.5. Polydimethylsiloxane (PDMS)
5.5.1. Global Polydimethylsiloxane (PDMS) Market, 2018 – 2030 (USD Million)
5.6. Others
5.6.1. Global Others Market, 2018 – 2030 (USD Million)
Chapter 6. Microfluidics Market: Technology Business Analysis
6.1. Microfluidics Market: Technology Movement Analysis
6.2. Lab-on-a-chip
6.2.1. Global Lab-on-a-chip Market, 2018 – 2030 (USD Million)
6.2.2. Medical
6.2.2.1. Medical Market, 2018 – 2030 (USD Million)
6.2.3. Non-medical
6.2.3.1. Non-medical Market, 2018 – 2030 (USD Million)
6.3. Organs-on-chips
6.3.1. Global Organs-on-chips Market, 2018 – 2030 (USD Million)
6.3.2. Medical
6.3.2.1. Medical Market, 2018 – 2030 (USD Million)
6.3.3. Non-medical
6.3.3.1. Non-medical Market, 2018 – 2030 (USD Million)
6.4. Continuous flow microfluidics
6.4.1. Global Continuous Flow Microfluidics Market, 2018 – 2030 (USD Million)
6.4.2. Medical
6.4.2.1. Medical Market, 2018 – 2030 (USD Million)
6.4.3. Non-medical
6.4.3.1. Non-medical Market, 2018 – 2030 (USD Million)
6.5. Optofluidics and microfluidics
6.5.1. Global Optofluidics and microfluidics Market, 2018 – 2030 (USD Million)
6.5.2. Medical
6.5.2.1. Medical Market, 2018 – 2030 (USD Million)
6.5.3. Non-medical
6.5.3.1. Non-medical Market, 2018 – 2030 (USD Million)
6.6. Acoustofluidics and microfluidics
6.6.1. Global Acoustofluidics and microfluidics Market, 2018 – 2030 (USD Million)
6.6.2. Medical
6.6.2.1. Medical Market, 2018 – 2030 (USD Million)
6.6.3. Non-medical
6.6.3.1. Non-medical Market, 2018 – 2030 (USD Million)
6.7. Electrophoresis and microfluidics
6.7.1. Global Electrophoresis and microfluidics Market, 2018 – 2030 (USD Million)
6.7.2. Medical
6.7.2.1. Medical Market, 2018 – 2030 (USD Million)
6.7.3. Non-medical
6.7.3.1. Non-medical Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Microfluidics Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Microfluidics Market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Target disease prevalence
7.2.2.3. Competitive Scenario
7.2.2.4. Regulatory Framework
7.2.2.5. U.S. Microfluidics Market, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Target disease prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Canada Microfluidics Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Microfluidics Market, 2018 – 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Target disease prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. UK Microfluidics Market, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target disease prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Germany Microfluidics Market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target disease prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. France Microfluidics Market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target disease prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Italy Microfluidics Market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target disease prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Spain Microfluidics Market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target disease prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Denmark Microfluidics Market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target disease prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Sweden Microfluidics Market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target disease prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Norway Microfluidics Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Microfluidics Market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target disease prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. Japan Microfluidics Market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target disease prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. China Microfluidics Market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target disease prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. India Microfluidics Market, 2018 – 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Target disease prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Australia Microfluidics Market, 2018 – 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Target disease prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Thailand Microfluidics Market, 2018 – 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Target disease prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. South Korea Microfluidics Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Microfluidics Market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target disease prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Brazil Microfluidics Market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target disease prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Mexico Microfluidics Market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target disease prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Argentina Microfluidics Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Microfluidics Market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target disease prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. South Africa Microfluidics Market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target disease prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Saudi Arabia Microfluidics Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target disease prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. UAE Microfluidics Market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target disease prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Kuwait Microfluidics Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles
8.4.1. Illumina, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. F. Hoffmann-La Roche Ltd
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PerkinElmer, Inc
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Agilent Technologies, Inc
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-Rad Laboratories, Inc
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Danaher Corporation
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Abbott
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Thermo Fisher Scientific Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Standard BioTools, Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives

List of Tables

Table 1 Some commercialized POCT devices based on NAT.
Table 2 List of FDA-approved microfluidic-based POC tests
Table 3 Research institutes in Canada working on microfabricated microfluidics
Table 4 Overview of magnetic, colorimetric, plasmonic, electrochemical, and lateral flow assays
Table 5 Several approaches for microfluidic PCR devices including commercial PCR devices
Table 6 Major types of micro mosaic immunoassays
Table 7 Particle-focusing techniques applied in microfluidic flow cytometry
Table 8 Comparison of detection of food allergens by commercial ELISA kits and the microfluidic ELISA biosensor
Table 9 Materials and their respective technologies for micro structuring
Table 10 Comparison of polymers with glass
Table 11 Distinctive features of continuous-flow microfluidics and their usage in materials synthesis
Table 12 Different applications of acoustofluidic separation
Table 13 List of established companies
Table 14 List of emerging companies (contd.)
Table 15 List of Secondary Sources
Table 16 List of Abbreviations
Table 17 Global Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 18 Global Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 19 Global Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 20 Global Microfluidics Market, by Region, 2018 - 2030 (USD Million)
Table 21 North America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 22 North America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 23 North America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 24 U.S. Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 25 U.S. Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 26 U.S. Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 27 Canada Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 28 Canada Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 29 Canada Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 30 Europe Microfluidics Market, by Country, 2018 - 2030 (USD Million)
Table 31 Europe Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 32 Europe Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 33 Europe Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 34 Germany Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 35 Germany Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 36 Germany Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 37 UK Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 38 UK Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 39 UK Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 40 Norway Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 41 Norway Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 42 Norway Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 43 Sweden Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 44 Sweden Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 45 Sweden Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 46 Denmark Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 47 Denmark Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 48 Denmark Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 49 France Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 50 France Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 51 France Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 52 Italy Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 53 Italy Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 54 Italy Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 55 Asia Pacific Microfluidics Market, by Country, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 59 China Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 60 China Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 61 China Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 62 Japan Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 63 Japan Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 64 Japan Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 65 India Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 66 India Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 67 India Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 68 Australia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 69 Australia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 70 Australia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 71 Thailand Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 72 Thailand Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 73 Thailand Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 74 Latin America Microfluidics Market, by Country, 2018 - 2030 (USD Million)
Table 75 Latin America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 76 Latin America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 77 Latin America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 78 Brazil Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 79 Brazil Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 80 Brazil Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 81 Mexico Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 82 Mexico Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 83 Mexico Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 84 Argentina Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 85 Argentina Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 86 Argentina Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 87 Middle East & Africa Microfluidics Market, by Country, 2018 - 2030 (USD Million)
Table 88 Middle East & Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 89 Middle East & Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 90 Middle East & Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 91 South Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 92 South Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 93 South Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 95 Saudi Arabia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 96 Saudi Arabia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 97 UAE Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 98 UAE Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 99 UAE Microfluidics Market, by Application, 2018 - 2030 (USD Million)
Table 100 Kuwait Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
Table 101 Kuwait Microfluidics Market, by Material, 2018 - 2030 (USD Million)
Table 102 Kuwait Microfluidics Market, by Application, 2018 - 2030 (USD Million)
※본 조사보고서 [세계의 마이크로 플루이딕스 시장 2024-2030 : 용도별 (의료/헬스 케어, 비의료), 재료별 (실리콘, 유리), 기술별, 지역별] (코드 : GRV24JAN047) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 마이크로 플루이딕스 시장 2024-2030 : 용도별 (의료/헬스 케어, 비의료), 재료별 (실리콘, 유리), 기술별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!